NeueHealth, Inc.
NEUE
$4.82
-$1.81-27.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 257.73M | 246.32M | 231.97M | 219.86M | 190.18M |
| Total Other Revenue | 739.16M | 787.04M | 873.37M | 940.94M | 905.45M |
| Total Revenue | 996.89M | 1.03B | 1.11B | 1.16B | 1.10B |
| Cost of Revenue | 822.11M | 865.86M | 933.34M | 996.58M | 932.29M |
| Gross Profit | 174.78M | 167.50M | 172.01M | 164.22M | 163.34M |
| SG&A Expenses | 270.92M | 301.80M | 301.85M | 314.55M | 337.84M |
| Depreciation & Amortization | 16.07M | 16.68M | 17.38M | 18.30M | 19.70M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.11B | 1.18B | 1.25B | 1.33B | 1.29B |
| Operating Income | -112.21M | -150.98M | -147.21M | -168.62M | -194.20M |
| Income Before Tax | -117.55M | -577.02M | -570.16M | -629.17M | -665.23M |
| Income Tax Expenses | 4.86M | -1.32M | -2.02M | -1.43M | -15.64M |
| Earnings from Continuing Operations | -122.41 | -575.70 | -568.14 | -627.74 | -649.59 |
| Earnings from Discontinued Operations | -440.41M | -493.89M | -532.39M | -638.07M | -813.44M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 201.14M | 131.44M | 108.17M | 114.35M | -127.52M |
| Net Income | -361.67M | -938.16M | -992.36M | -1.15B | -1.59B |
| EBIT | -112.21M | -150.98M | -147.21M | -168.62M | -194.20M |
| EBITDA | -90.28M | -128.43M | -123.97M | -144.45M | -154.63M |
| EPS Basic | -51.16 | -123.67 | -130.72 | -150.87 | -207.03 |
| Normalized Basic EPS | 14.88 | 1.86 | -1.42 | -2.95 | -34.77 |
| EPS Diluted | -51.16 | -123.67 | -130.72 | -150.87 | -207.03 |
| Normalized Diluted EPS | 14.88 | 1.86 | -1.42 | -2.95 | -34.77 |
| Average Basic Shares Outstanding | 32.57M | 32.26M | 31.97M | 31.79M | 31.69M |
| Average Diluted Shares Outstanding | 32.57M | 32.26M | 31.97M | 31.79M | 31.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
